Market News & Trends
Vaxart Announces Positive Preclinical Data for its Oral COVID-19 Vaccine Program
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, recently announced it has obtained positive…
Ascendia Joins the Fight Against COVID-19; Developing Formulations
Ascendia Pharmaceuticals, a specialty CDMO company engaged in the design, formulation, optimization, and manufacture of poorly soluble molecules for various dosage forms with patent-protected technology…
Arcutis Announces Enrollment of First Patient in Phase 1/2b Study
Arcutis Biotherapeutics, Inc. recently announced it has enrolled the first patient in Phase 1/2b study of ARQ-252, a potent and highly selective topical small molecule…
COVID-19: Gattefossé Takes Measures & Continues to be Operational
Gattefossé - provider of personal care ingredients and pharmaceutical excipients - is committed to ensuring the protection of its employees and to manufacturing and delivering,…
New COVID-19 Clinical Trial Supported by Octapharma USA
Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, CA, focused on treating the most critical patients at the….
TFF Pharmaceuticals Announces R&D Collaboration for a Universal Influenza Vaccine
TFF Pharmaceuticals, Inc. recently announced that it has entered into a research collaboration with the University of Georgia’s Center for Vaccines and Immunology (CVI), along with….
HALIX Enters Collaboration for GMP Manufacturing of a COVID-19 Vaccine
HALIX B.V. has recently joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of….
Samsung Bioepis Announces US Launch of Oncology Biosimilar for Early & Metastatic HER2-Overexpressing Breast Cancer & Metastatic Gastric Cancer
Samsung Bioepis Co., Ltd. recently announced today that ONTRUZANT (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN (trastuzumab) for the treatment of….
Hovione's Inhaler for High-Dose Delivery Earns Product Design Award
Hovione Technology recently announced its innovative 8Shot Dry Powder Inhaler (DPI) enabling high-dose drug delivery to the lungs has received the Red Dot 2020 Product…
Guardion Health Sciences Announces Launch of Immuno-Supportive/Anti-Oxidant Complex
Guardion Health Sciences, Inc. recently announced that its immuno-supportive/anti-oxidant complex, labeled acuMMUNE , is now commercially available. acuMMUNE is a unique nutraceutical formulation designed with…
Biomarkers Heavily Used as Diagnostic Tools in COVID-19 Trials
Biomarkers are a beneficial tool in the search for a COVID-19 vaccine and will help speed up clinical trials, reduce costs of development, guide subject…
Celsion Reports Sufficient Events Have Been Reached for the Second Interim Analysis of the Phase 3 OPTIMA Study
Celsion Corporation recently announced the prescribed minimum number of events of 158 patient deaths has been reached for the second pre-specified interim analysis of the…
7 Hills Pharma Announces COVID-19 Vaccine Program Targeting At-Risk Elderly
7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases, recently announced…
Vir Biotechnology Announces VIR-2218 Demonstrates Dose-Dependent & Durable Reductions of Hepatitis B Surface Antigen in Phase 1/2 Trial
Vir Biotechnology, Inc. recently announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy…
Proveris to Present: The Effect of Ethanol Concentration on pMDI Evaporation Fraction
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced that on April 26…
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19
OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….
Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology
SIRION Biotech GmbH recently announced that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST for use in….
Cambrex Completes Biopharmaceutical Expansion at its Durham Facility
Cambrex recently announced it has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, NC, site. Biopharmaceutical analysis services were initially launched at…
